Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Baobei Zhi Ke Oral Solution is a Traditional Chinese Medicine (TCM) therapeutic developed by the Gansu Yasheng Academy of Sciences for the treatment of respiratory conditions. It is primarily indicated for cough resulting from acute tracheobronchitis or acute exacerbations of chronic bronchitis, specifically for patients presenting with the wind-heat attacking the lung pattern in TCM diagnosis. The formulation is administered as an oral solution and has undergone Phase 3 clinical testing in China to evaluate its antitussive and expectorant efficacy compared to established treatments like Jizhi Syrup.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Baobei Zhi Ke Oral Solution.